Join the Gleevec group to help and get support from people like you.
Gleevec News
FDA Approves Imkeldi (imatinib) Oral Solution for the Treatment of Certain Forms of Leukemia and Other Cancers
CAMBRIDGE, Mass.-- November 25, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved Imkeldi (imatinib) oral solution, the fir...
FDA Approves Gleevec for Children with Acute Lymphoblastic Leukemia
January 25, 2013 – The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute...
FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST)....
FDA Medwatch Alert: Gleevec (imatinib mesylate)
[Posted 10/19/2006] Novartis and FDA notified healthcare professionals about revisions to the PRECAUTIONS section of the prescribing information, describing the occasional occurrence of severe...
Further information
Related condition support groups
Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia